Biểu đồ giá cổ phiếu ARGX
ARGX Thu nhập
argenx SE
$782.17
-0.65%
$-5.13
Khi đóng cửa: May 08, 16:00:00 GMT-4
$790
1%
$7.83
Phiên sau giờ: May 08, 20:00:00 GMT-4
Quay lại
argenx SE (ARGX) Thu nhập
Thống kê chính
Giá đóng cửa trước
$787.31
Giá mở cửa
$787.08
Phạm vi ngày
$778.71 - $792
Phạm vi 52 tuần
$510.05 - $934.62
Khối lượng
345.9K
Khối lượng trung bình
341.0K
Tỷ suất cổ tức
--
EPS (TTM)
19.59
Vốn hóa thị trường
$49.1B
argenx SE là gì?
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. The company is headquartered in Amsterdam, Noord-Holland. The company went IPO on 2014-07-10. The company is primarily engaged in creating and developing a pipeline of differentiated antibody therapeutics for the treatment of severe autoimmune diseases using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The firm develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. The company includes, but is not limited to: Empasiprubart, a complement inhibitor targeting C2, blocking the function of both the classical and lectin pathways, while leaving the alternative pathway intact, ARGX-119 an antagonist to the MuSK receptor with potential in multiple neuromuscular indications.
